Shon Chakrabarti MD MPH
@shonmd
Followers
4K
Following
4K
Media
378
Statuses
2K
Chief Medical Officer @recormedical | Girl Dad x 3 | Top 25 MedTech Executive of 2025 | Interventional Cardiologist | Tweets are my own
San Clemente, CA
Joined March 2010
Listen to Dr. Angela Brown and Recor’s CMO, Dr. Shon Chakrabarti discussion about all things Ultrasound Renal Denervation (uRDN) and learn about Dr. Brown’s experience on treating hypertension patients with uRDN. Click now to listen: https://t.co/ge3bqlL3cb Prescription only.
0
1
0
Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z
#Hypertension #ParadiseURDN
0
2
0
Attending AHA #Hypertension2025 in Baltimore? Join our breakfast symposium and listen to our expert speakers talk about Guidelines and Future of Hypertension: Where does Renal Denervation fit? Date: Friday September 5, 2025 Time: 7:15am – 7:45am ET Location: Baltimore Marriott
0
1
1
Nice summary here by @MassDevice highlighting approval of the #Paradise #uRDN system in #Japan
#Data integrity, solid #study design - this is how you get to "first in Japan for a medical device indicated for resistant hypertension." https://t.co/DgjQSI76ic
massdevice.com
Otsuka Medical Devices announced that Japanese authorities approved the Recor Medical Paradise ultrasound renal denervation (uRDN) system.
0
0
0
Drive to Blood Pressure Goal Paradise™ Ultrasound RDN procedure treats hypertension by calming the overactive renal nerves. When medications and lifestyle changes are not enough, it delivers safe and sustained reductions proven across multiple sham-controlled trials. (1-4)
1
2
3
Drive to Blood Pressure Goal Paradise™ Ultrasound RDN procedure treats hypertension by calming the overactive renal nerves. When medications and lifestyle changes are not enough, it delivers safe and sustained reductions proven across multiple sham-controlled trials. (1-4)
1
1
2
We were honored to welcome #LimFlow patient John O'Connell, who went from facing major amputation to regaining mobility. His journey highlights why we’re passionate about providing hope to #CLTI patients with limited options. Watch John's story: https://t.co/DsJxcZV6Fg
0
1
2
We are looking for cardiologist, interventionalist, and EP docs to join our group in southeast Michigan. Busy private practice with opportunities for teaching and research. We can sponsor visas. Must be board certified or eligible. DM me if you are interested.
7
18
110
Better, together 💪🏽 This 💯 “With Inari as part of Stryker, we will be better positioned to help our customers enhance the quality of care and improve the lives of vascular patients worldwide” #medtech #innovation #vte #pad #clti @InariMedical @CLI_LimFlow
We are excited to announce that Inari Medical entered into a definitive agreement to be acquired by Stryker. Joining the Stryker family will allow us to build on our tremendous progress in pioneering an entirely new approach to helping patients with Venous Thromboembolism.
0
0
2
LimFlow by Inari Medical continues to help so many by all the work they do. Listen to our latest episode with Shon Chakrabarti MD MPH and Michael Siah to listen to their story. Available on Spotify and YouTube. 🔗Links below 🎵 https://t.co/xjdjz4Jqzy 🎬
0
2
5
Confidence is key 🔑 and it also helps to have a group of people you can collaborate with too. Watch our latest episode on @CLI_LimFlow by @InariMedical with @shonmd and @michaelcsiah (at @UTSWMedCenter). Available now on Spotify and YouTube. 🔗Links below 🎵
0
5
22
Watch our latest episode on @CLI_LimFlow, by @InariMedical, and feel apart of the community along with @michaelcsiah M.D (at @UTSWMedCenter), @shonmd, @monteromiguel and Lucas Ferrer. Available now on Spotify and YouTube. 🔗Links below 🎵 https://t.co/xjdjz4ISK0 🎬
0
3
11
Read this weeks newsletter on “@CLI_LimFlow, by @InariMedical, the future of CLTI solutions with Shon Chakrabarti MD MPH and Michael Siah M.D (at @UTSWMedCenter)”. Sign up below to get newsletter updates every Thursday! https://t.co/aLGEJNAcmb
0
7
15
🚨 New Episode Alert! 🚨 💡 Shon Chakrabarti & Michael Siah - Limflow: The Future of CLTI Solutions Discover how Limflow's acquisition by Inari is reshaping CLTI treatments, from innovative DBAs to economic impacts on limb salvage programs. 🎙️ Highlights: 🔹 Inari-Limflow
0
1
6
Dr. Daniel Clair presents PROMISE trial data on a deep venous arterialization panel. @VEITHsymposium @scarolinavasc. Gentlepeople, this is no humbug. #vascsurg
1
1
8
Late-breaking second year results from the PROMISE II trial showed that the LimFlow system achieved strong outcomes for avoiding amputations and promoting limb salvage among “no-option” patients with chronic limb-threatening ischemia (CLTI). https://t.co/jzNmeWPoH8
cardiacwire.com
Late-breaking second year results from the PROMISE II trial showed that the LimFlow system achieved strong outcomes for avoiding amputations and promoting limb salvage among “no-option” patients with...
0
1
2
PROMISE II Trial Evaluates TADV With Inari’s LimFlow System #VIVA24
evtoday.com
November 5, 2024—Two-year outcomes from the PROMISE II trial assessed transcatheter arterialization of the deep veins (TADV) using the LimFlow S
0
1
2
One week until our next podiatry and wound care webinar! Join us for Transforming CLTI Management! This session will cover key topics like addressing the unmet need of CLTI, and identifying and navigating the journey of the TADV patient. Register here: https://t.co/3JaaMKUgEZ
1
3
6
.#PEERLESS RCT results will pave the way for percutaneous suction thrombectomy for Venous Thrombo-Embolism. Kudos to all the physicians @carin_gonsalves @wissamj123 & to @InariMedical leadership for their commitment to clinical evidence @emkhairy @shonmd => https://t.co/Ce3WIAhK5p
0
1
6